Novacyt (NCYT.L): FDA Emergency Use Authorization for COVID-19 test | Creo Medical Group (CREO.L): FDA clearance for Haemostasis Device
23 Mar 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Novacyt SAS (NCYT:LON), 68.1 | Creo Medical Group Plc (CREO:LON), 36.0
- Published:
23 Mar 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Novacyt (NCYT.L): FDA Emergency Use Authorization for COVID-19 test | Creo Medical Group (CREO.L): FDA clearance for Haemostasis Device